Enochian Biosciences is a pre-clinical stage biotech that purchased its HIV drug IP from Weird Science, LLC. ENOB's lead scientist and HIV IP inventor does not appear to have any biotech experience, ...
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when ...
It's not every day that a biotech's scientific co-founder is arrested on murder-for-hire charges. But the aftermath of that arrest is just what Enochian Biosciences' CEO faces now—and he's fighting ...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Enochian BioSciences, Inc. (NASDAQ: ENOB) between ...
LOS ANGELES, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious disease and cancer, announces the expansion of its infectious ...
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems ...
LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences is working to solve our greatest public health threats like HIV, cancer, and coronavirus. The company’s underlying ...
If convicted of the federal grand jury charges against them, Gumrukcu and Eratay face mandatory life in prison or the death penalty. Shares of the company’s stock plummeted 38.8% on the news. 3 Summer ...
Enochian BioSciences said its cellular therapy could potentially allow people with HIV to stop antiviral treatment for long periods. Its request to the FDA was based on the results of a 54-year-old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results